A Reference Laboratory Surveillance on Fungal Isolates from Patients with Haematological Malignancy in Japan.

Yutaro Hino, Akira Watanabe, Rio Seki, Shokichi Tsukamoto, Yusuke Takeda, Emiko Sakaida, Katsuhiko Kamei

Abstract read

In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yutaro HinoMedical Mycology Research Center, Division of Clinical Research, Chiba University, Chiba 260-8673, Japan.ORCID 0000-0001-6938-6130

Akira WatanabeMedical Mycology Research Center, Division of Clinical Research, Chiba University, Chiba 260-8673, Japan.ORCID 0000-0002-3057-2937

Rio SekiMedical Mycology Research Center, Division of Clinical Research, Chiba University, Chiba 260-8673, Japan.

Shokichi TsukamotoDepartment of Hematology, Chiba University Hospital, Chiba 260-8673, Japan.

Yusuke TakedaDepartment of Hematology, Chiba University Hospital, Chiba 260-8673, Japan.

Emiko SakaidaDepartment of Hematology, Chiba University Hospital, Chiba 260-8673, Japan.ORCID 0000-0002-7254-1928

Katsuhiko KameiMedical Mycology Research Center, Division of Clinical Research, Chiba University, Chiba 260-8673, Japan.

Funding

Japan Agency for Medical Research and Development JP21jm0110015

6 · The paper itself

Abstract

Invasive fungal disease (IFD) in patients with haematological disorders is a fatal disease, making rapid identification and treatment crucial. However, the identification of the causative fungus is often difficult, sometimes even impossible. There have been few reports concerning the causative species of IFD. This study aimed to investigate the epidemiology and causative organism of IFD in patients with haematological diseases in Japan. We analyzed the IFD cases among the patients with haematological malignancies identified at the Medical Mycological Research Center, Chiba University, between 2013 and 2019. The most common underlying disease was acute myeloid leukaemia (34.3%). Forty-six point one percent of IFD patients received haematopoietic stem cell transplantation (HSCT). The major pathogens were

Indexed as

AspergillusCandidaFusariumhaematological disorderimmunocompromised hostinvasive fungal disease

Identifiers

PMID34682228

DOI10.3390/jof7100806

PMCPMC8537693

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.